Hormone Therapy

Options for endometriosis management range from surgical excision to medications to general lifestyle modifications, such as diet changes and stress reduction.

Outcomes of using menopausal hormone therapy beyond age 65 years varied based on hormone therapy types, administration and strengths among women on Medicare, researchers reported in Menopause.

The American Urological Association released a clinical practice guideline pertaining to salvage therapy for men with prostate cancer.

Among transgender adults who received gender-confirming care as adolescents, those living in transgender-supportive states are less likely to avoid health care than those who live in unsupportive states, according to study data.

Sentinel lymph node biopsy may be omitted in certain patients with early-stage breast cancer, according to findings presented at American Society of Breast Surgeons Annual Meeting.

Abnormal laboratory results are rare among adolescents receiving gender-affirming hormone therapy, according to study results published in Pediatrics.

The prolonged use of certain progestogen hormone drugs — such as medrogestone, medroxyprogesterone acetate and promegestone — increased the risk for developing intracranial meningioma, according to data published in The BMJ.

Yolanda Bryce, MD, still remembers her patient’s shock.

Women reported a significantly lower frequency of moderate to severe menopausal vasomotor symptoms while taking elinzanetant vs. placebo, according to the results of a phase 3 trial.

Fezolinetant and elinzanetant are both promising nonhormone therapies for managing vasomotor symptoms among postmenopausal women, with favorable safety profiles for up to 12 weeks, according to a systematic review published in Menopause.